Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Heterogeneous Copper Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110563659A reveals green heterogeneous copper catalysis for triazoles. Enables cost reduction in API intermediate manufacturing and scalable supply chain solutions.
Patent CN114805031A reveals efficient aryl halide hydroxylation using recyclable CuPc catalysts, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN114213440B reveals a novel PVC-copper catalyzed route for high-purity 2-boron alkenyl oxygen ether intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Patent CN114656494B reveals a novel chitosan copper catalyst for allyl borate synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN109608401A reveals chitosan-copper catalysis for diarylamines. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes.
Patent CN113444076A details a green three-component synthesis for fluorinated quinoxalinones, offering recyclable catalysis and reduced metal residues for pharmaceutical manufacturing.
Patent CN113444076A reveals a recyclable chitosan-copper catalyst for synthesizing fluorinated quinoxalinones, offering sustainable cost reduction and high purity for pharma manufacturing.
Patent CN112321628A reveals a green water-based copper catalytic method for beta-silyl nitriles, offering significant cost reduction and scalability for pharmaceutical intermediates.
Patent CN112142656B reveals a green biomass-copper catalyzed route for sulfonyl pyridine amides, offering cost-effective manufacturing and scalable pharmaceutical intermediate production.
Patent CN112778351B details a ligand-free, green synthesis of beta-dimethylphenyl silicon substituted aromatic nitro compounds using recyclable cellulose-supported copper nanoparticles.
Patent CN113429349A details a heterogeneous copper-catalyzed route for high-purity benzimidazoles, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel heterogeneous catalytic method for benzimidazole synthesis offering mild conditions and recyclable catalysts for cost-effective production.
Patent CN113429349A reveals a recyclable Cu/g-C3N4 method for high-yield benzimidazole synthesis, offering cost-effective pharma intermediate solutions.
Patent CN113429349A details a novel Cu/g-C3N4 catalyzed route for 2-trifluoromethyl benzimidazoles, offering mild conditions and recyclable catalysts for cost-effective API intermediate manufacturing.